ARRY-614

· Array BioPharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARRY-614, covering 2025-11-06 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab [Phase 1, Phase 2]